<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01509521</url>
  </required_header>
  <id_info>
    <org_study_id>2011-006103-35</org_study_id>
    <secondary_id>SJ-271</secondary_id>
    <nct_id>NCT01509521</nct_id>
  </id_info>
  <brief_title>The Oxygenation of the Brain During Caesarean Section</brief_title>
  <acronym>OBDUC</acronym>
  <official_title>The Oxygenation of the Brain During Caesarean Section. A Comparison of Ephedrine Versus Phenylephrine</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Naestved Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Naestved Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the impact of phenylephrine versus ephedrine on
      organ perfusion, in women undergoing caesarean section receiving spinal anaesthesia. The
      organ perfusion is estimated by measuring the maternal cerebral oxygenation by
      NIRS(Near-infrared spectroscopy)and the foetal heartrate.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2012</start_date>
  <completion_date type="Actual">August 2012</completion_date>
  <primary_completion_date type="Actual">July 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Frontal lobe cerebral oxygenation</measure>
    <time_frame>Participants will be followed for the time in the operation theatre of the hospital stay, an expected average of 1 hour</time_frame>
    <description>Determine the frontal lobe cerebral oxygantion by Near-Infrared Spectroscopy (NIRS),from before induction of spinal anaesthesia to end of surgery.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Foetal heartrate</measure>
    <time_frame>Participants will be followed for the time in the operation theatre of the hospital stay, an expected average of 1 hour</time_frame>
    <description>From before induction of spinal anaesthesia to 15 min after delivery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mean arterial pressure</measure>
    <time_frame>Participants will be followed for the time in the operation theatre of the hospital stay, an expected average of 1 hour</time_frame>
    <description>The mean arterial pressure is measures from before induction of spinal anaesthesia to end of surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac output</measure>
    <time_frame>Participants will be followed for the time in the operation theatre of the hospital stay, an expected average of 1 hour</time_frame>
    <description>The cardiac output is measures from before induction of spinal anaesthesia to end of surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Umbilical cord pH and Base excess</measure>
    <time_frame>Blood analysis taken immediately after the the clamping of the umbilical cord, an average of 20 minutes.</time_frame>
    <description>The umbilical cord blood analysis for evaluation of the newborn's acid-base status is taken immediately after delivery. It is the most objective way of assessing the fetal metabolic condition at birth.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">24</enrollment>
  <condition>Complications; Cesarean Section</condition>
  <arm_group>
    <arm_group_label>Ephedrine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Phenylephrine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ephedrine</intervention_name>
    <description>An infusion with a maximum of 3 mg/minute for maximum 60 minutes or if sideeffects develope.</description>
    <arm_group_label>Ephedrine</arm_group_label>
    <other_name>Efedrin</other_name>
    <other_name>Ephedrine hydrochloride</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Phenylephrine</intervention_name>
    <description>An infusion of maximum 4 mg/hour for maximum 60 minutes.</description>
    <arm_group_label>Phenylephrine</arm_group_label>
    <other_name>Phenylephrine Hydrochloride</other_name>
    <other_name>Metaoxedrin</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy pregnant women

          -  Over 18 years old

          -  ASA 1-2

          -  Undergoing elective caesarean section

          -  Height over 160 cm or under 180 cm

        Exclusion Criteria:

          -  Allergic reactions to ephedrine or phenylephrine

          -  High blood levels of bilirubin

          -  HELPP syndrome

          -  Preeclampsia (pregnancy-induced hypertension)

          -  Non singleton pregnancies
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Visti Foss</last_name>
    <role>Principal Investigator</role>
    <affiliation>Naestved Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Naestved Hospital</name>
      <address>
        <city>Naestved</city>
        <zip>4700</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>August 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 8, 2012</study_first_submitted>
  <study_first_submitted_qc>January 12, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 13, 2012</study_first_posted>
  <last_update_submitted>August 5, 2012</last_update_submitted>
  <last_update_submitted_qc>August 5, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 7, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Naestved Hospital</investigator_affiliation>
    <investigator_full_name>Visti Foss</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Spectroscopy, Near-Infrared</keyword>
  <keyword>Fetal heartrate</keyword>
  <keyword>Ephedrine</keyword>
  <keyword>Phenylephrine</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Phenylephrine</mesh_term>
    <mesh_term>Oxymetazoline</mesh_term>
    <mesh_term>Ephedrine</mesh_term>
    <mesh_term>Pseudoephedrine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

